Cargando…

Health technology assessment: the process in Brazil

OBJECTIVES. To describe, analyze, and compare the opinions of decisionmakers involved in the health technology assessment (HTA) process in Brazil in 2011. METHODS. A cross-sectional study was conducted using a structured questionnaire to evaluate the opinions of a convenience sample of health care p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lessa, Fernanda, Ferraz, Marcos Bosi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Organización Panamericana de la Salud 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660842/
https://www.ncbi.nlm.nih.gov/pubmed/28614463
http://dx.doi.org/10.26633/RPSP.2017.25
_version_ 1783439368900313088
author Lessa, Fernanda
Ferraz, Marcos Bosi
author_facet Lessa, Fernanda
Ferraz, Marcos Bosi
author_sort Lessa, Fernanda
collection PubMed
description OBJECTIVES. To describe, analyze, and compare the opinions of decisionmakers involved in the health technology assessment (HTA) process in Brazil in 2011. METHODS. A cross-sectional study was conducted using a structured questionnaire to evaluate the opinions of a convenience sample of health care professionals from both the public and private health care systems (HCS). The survey collected demographic data for each respondent along with their input on national regulations. Data analysis included descriptive statistics, including chi-square tests to compare groups. RESULTS. Of the 200 completed questionnaires, 65% of the respondents were 31–50 years of age; 36% were HCS managers, 49.3% from the public and 50.7% from the private system. The majority of respondents (85%) considered the time permitted for submission of new technology to be inadequate; 88% also stated that the composition of the evaluation committee needed improvement. Respondents from the private health system more frequently stated that submission times were inappropriate (P = 0.019) and that the deadline for a decision by the committee should be defined (P = 0.021), with a maximum of no more than 180 days / 6 months (P < 0.001). CONCLUSIONS. Respondents indicated that the HTA process should be improved to meet their expectations. Given that new legislation has been enacted to continuously accept submissions, to make decisions within 180 days, and to expand the committee to represent more stakeholders, most of the respondents concerns have been addressed. This study is valuable as an historical analysis of HTA process improvement. Further surveys are needed to track the new HTA process, its application, and its contribution to health care needs in Brazil.
format Online
Article
Text
id pubmed-6660842
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Organización Panamericana de la Salud
record_format MEDLINE/PubMed
spelling pubmed-66608422019-08-07 Health technology assessment: the process in Brazil Lessa, Fernanda Ferraz, Marcos Bosi Rev Panam Salud Publica Original Research OBJECTIVES. To describe, analyze, and compare the opinions of decisionmakers involved in the health technology assessment (HTA) process in Brazil in 2011. METHODS. A cross-sectional study was conducted using a structured questionnaire to evaluate the opinions of a convenience sample of health care professionals from both the public and private health care systems (HCS). The survey collected demographic data for each respondent along with their input on national regulations. Data analysis included descriptive statistics, including chi-square tests to compare groups. RESULTS. Of the 200 completed questionnaires, 65% of the respondents were 31–50 years of age; 36% were HCS managers, 49.3% from the public and 50.7% from the private system. The majority of respondents (85%) considered the time permitted for submission of new technology to be inadequate; 88% also stated that the composition of the evaluation committee needed improvement. Respondents from the private health system more frequently stated that submission times were inappropriate (P = 0.019) and that the deadline for a decision by the committee should be defined (P = 0.021), with a maximum of no more than 180 days / 6 months (P < 0.001). CONCLUSIONS. Respondents indicated that the HTA process should be improved to meet their expectations. Given that new legislation has been enacted to continuously accept submissions, to make decisions within 180 days, and to expand the committee to represent more stakeholders, most of the respondents concerns have been addressed. This study is valuable as an historical analysis of HTA process improvement. Further surveys are needed to track the new HTA process, its application, and its contribution to health care needs in Brazil. Organización Panamericana de la Salud 2017-03-23 /pmc/articles/PMC6660842/ /pubmed/28614463 http://dx.doi.org/10.26633/RPSP.2017.25 Text en https://creativecommons.org/licenses/by/4.0/  
spellingShingle Original Research
Lessa, Fernanda
Ferraz, Marcos Bosi
Health technology assessment: the process in Brazil
title Health technology assessment: the process in Brazil
title_full Health technology assessment: the process in Brazil
title_fullStr Health technology assessment: the process in Brazil
title_full_unstemmed Health technology assessment: the process in Brazil
title_short Health technology assessment: the process in Brazil
title_sort health technology assessment: the process in brazil
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660842/
https://www.ncbi.nlm.nih.gov/pubmed/28614463
http://dx.doi.org/10.26633/RPSP.2017.25
work_keys_str_mv AT lessafernanda healthtechnologyassessmenttheprocessinbrazil
AT ferrazmarcosbosi healthtechnologyassessmenttheprocessinbrazil